InnoPharm-2026 Announces World-Class Plenary & Keynote Speaker Lineup

A powerhouse lineup of global thought leaders driving the future of pharmaceutical innovation, translational science, and advanced therapeutics.

The organizing committee of Innovations in Pharma R&D (InnoPharm-2026) today announced an exceptional lineup of globally renowned Plenary and Keynote Speakers, who will present their latest research and insights in-person and virtually at the upcoming conference.

Bringing together leading experts from top academic institutions and research organizations, the conference will highlight breakthrough innovations shaping the future of pharmaceutical research, drug discovery, and translational medicine.

Distinguished Plenary & Keynote Speakers Include:

• Donald E. Ingber – Founding Director, Wyss Institute, Harvard University (Boston, MA); a pioneer in biologically inspired engineering and organ-on-chip technologies.
• Paul A. Insel – Distinguished Professor, University of California San Diego (San Diego, CA); expert in pharmacology and GPCR signaling.
• Rhoda Alani – Brigham and Women's Hospital & Harvard Medical School (Boston, MA); renowned for melanoma and skin cancer research.
• Martin Schwartz – Professor, Yale School of Medicine (New Haven, CT); global leader in mechanobiology and vascular science.
• Ruben Abagyan – Professor, University of California San Diego (San Diego, CA); pioneer in computational drug discovery.
• Wolfgang Sadee – Professor Emeritus, University of California San Francisco & CSO, Aether Therapeutics (Austin, TX); authority in pharmacogenomics and personalized medicine.
• Debbie C. Crans – Professor, Colorado State University (Fort Collins, CO); expert in bioinorganic and metal-based therapeutics.
• Liwu Li – Professor, Virginia Polytechnic Institute and State University (Blacksburg, VA); leader in immunology and inflammation research.
• Joseph C. Wu – Professor, Stanford University (Stanford, CA); expert in stem cell science and cardiovascular precision medicine.
• Nathan D. Wong – Professor, University of California Irvine (Irvine, CA); leader in preventive cardiology and population health.
• Ernst Wagner – Chair, Pharmaceutical Biotechnology, Ludwig Maximilian University of Munich (Germany); leader in gene therapy and advanced drug delivery systems.

Advancing the Future of Pharma R&D:

The plenary and keynote sessions at InnoPharm-2026 will focus on transformative areas including:

• Artificial intelligence in drug discovery
• Precision medicine and pharmacogenomics
• Oncology, cardiovascular, and immunology innovations
• Gene therapy and advanced drug delivery
• Translational and clinical research integration and many more.

The hybrid format ensures global accessibility, enabling attendees to engage with experts either onsite in Boston or through a fully interactive virtual platform.

About InnoPharm-2026

Innovations in Pharma R&D (InnoPharm-2026) is a premier international conference dedicated to advancing pharmaceutical research and development. The event brings together scientists, industry leaders, and innovators to exchange knowledge, foster collaborations, and accelerate the translation of scientific discoveries into real-world therapies.

Event Details:
📅 November 02–04, 2026
📍 Boston, MA | Hybrid

Join us now at: https://pharm-science.com/register

See you in Boston.

Contact
Gayatri Srinivas
Conference Manager